Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cell therapies wake up and smell the coffee

July 3, 2018

JCR initiates phase II study of JR-141 as treatment of Hunter syndrome in Brazil

July 2, 2018

Patient enrollment ongoing in phase I/II study of SOBI-003 in pediatric MPS IIIA

July 2, 2018

Positive CHMP opinion granted for Mepsevii for the treatment of mucopolysaccharidosis VII

July 2, 2018

FDA grants approval for Qbrexza cloth as treatment of primary axillary hyperhidrosis

July 2, 2018

ZYDG-2, a GPR40 agonist for potential treatment of type 2 diabetes

July 2, 2018

INDIGO-1 study of gemcabene in severe hypertriglyceridemia meets primary endpoint

June 29, 2018

Benefits seen with MEDI-0382 in overweight/obese subjects with type 2 diabetes

June 28, 2018

Part A data from phase III HOPE study of voxelotor in sickle cell disease show primary endpoint met

June 28, 2018

Pivot plans IND filing to begin clinical trials with PVT-005

June 27, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...